Forth Therapeutics

Forth Therapeutics, the operator of a biotechnology company, plans to develop precision treatments for fibrotic diseases. The company's platform uses advanced computational models and machine learning algorithms, combined with single-cell and spatial genomics approaches, to identify anti-fibrotic targets with high accuracy, enabling researchers to create high-definition maps of fibrotic diseases, thereby accelerating the discovery and development of precision medicines.